Statistical Data on Drugs in Rhode Island
Rhode Island experiences substantial hurdles related to substance misuse and fatal overdoses, although recent patterns reveal promising indicators of progress. Historically, the state has recorded levels exceeding national benchmarks in multiple categories of drug consumption. Nevertheless, 2024 represented a pivotal moment, as fatalities from overdoses decreased for the second year running. This thorough statistical examination explores patterns of drug consumption, trends in overdose incidents, availability of treatment services, and variations across demographics in substance misuse throughout Rhode Island, utilizing state monitoring information, federal criminal justice data, and public health assessments from 2022-2024.
Fatal Overdose Statistics
Overdose Fatalities (2022-2024)
-
- 2022: 436 fatalities
- 2023: 404 fatalities (7.3% reduction from 2022)
- 2024: 329 fatalities (18.6% reduction from 2023; 25% reduction from 2022)
Rhode Island has accomplished notable advancement toward achieving its objective of decreasing overdose fatalities by 30% by 2030.
Rates of Overdose Mortality
| Indicator | Rhode Island | National Benchmark | Variance |
| OD mortality rate (per 100,000) | 38.1 | 32.7 | +16.35% elevated |
| Opioid OD mortality rate (per 100,000) | 32.2 | 24.0 | +34.2% elevated |
| Yearly OD fatalities | 424 | – | – |
| Share of total deaths attributed to OD | 4.06% | – | – |
| RI’s portion of countrywide OD fatalities | 0.39% | – | – |
Notwithstanding recent progress, Rhode Island’s overdose mortality rates continue to be considerably above national benchmarks.
Overdose Fatalities Categorized by Substance
2024 Substance Participation
- Cocaine-involved fatalities: 61% (initial occurrence exceeding fentanyl since 2013)
- Fentanyl-involved fatalities: 57%
- Total opioid-involved fatalities: 69% (decreased from 85% in 2023)
- Fatalities involving cocaine and fentanyl combined: 118 incidents
- Xylazine participation in opioid fatalities: 37%
Historical Contrast (2023 versus 2024)
- Opioid-involved overdoses: 85% (2023) → 69% (2024)
- This signifies a substantial transformation in the overdose environment
Extended-term Patterns in Substance Categories
- 2009: Prescription medications represented 62% of overdose fatalities
- 2020: Prescription medications fell to 9%; illicit substances (fentanyl, cocaine) increased to 72%
- 2024: Mixtures of illicit and prescription substances: 34% (peak since no earlier than 2009)
A significant trend shift transpired in 2024, with cocaine surpassing fentanyl as the most prevalent substance in fatal overdoses.
2007 Mortality Comparison
| Cause of Fatality | Count |
| Drug-prompted fatalities | 142 |
| Automobile accidents | 85 |
| Firearms | 37 |
Even in 2007, drug fatalities markedly surpassed both automobile deaths and firearm deathse.
Opioid-Focused Statistics (2023 Information)
- Total opioid overdose fatalities: 347
- Opioids as element in all OD fatalities: 84.0%
- Synthetic opioids (e.g., fentanyl) in opioid fatalities: 91.4%
- Prescription opioids in opioid fatalities: 12.4%
- Prescription frequency: Physicians write sufficient prescriptions for 30.5% of inhabitants
Synthetic opioids, especially fentanyl, control the opioid emergency, being present in more than 9 out of 10 opioid fatalities.
Youth Drug Consumption Statistics (2022-2023)
Past Month Use
- Illicit substances: 5,000 adolescents (7.38%)
- Marijuana: Approximately 100% of adolescent drug consumers reported marijuana consumption
- Alcohol: 5,000 adolescents (8.36%)
Past Year Use
- Marijuana: 13.22%
- Cocaine: 0.25%
- Methamphetamine: 0.08%
- Pain medications: 1.64%
High School Pupil Substance Consumption (2023 Youth Risk Behavior Assessment)
- Present alcohol intake: 18%
- Present marijuana consumption: 20%
- Present e-cigarette consumption: 17%
- Present binge alcohol intake: 9%
- Present cigarette consumption: 3%
- Ever misapplied prescription pain medication: 11%
E-cigarettes and marijuana display nearly equivalent prevalence among high school students, indicating vaping has become as commonplace as conventional substance consumption among adolescents.
Youth Substance Use Disorders (2022-2023)
- Drug Consumption Disorder (DUD): 7.49% of 12-17 year-olds
- Alcohol Consumption Disorder (AUD): 3.19% of 12-17 year-olds
Historical Youth Drug Use Patterns
Past-Month Marijuana Use (2017-2019)
- Rhode Island: 9.3%
- Regional benchmark: 10.8%
- National benchmark: 6.8%
- RI elevated than national but reduced than regional
Past-Month Illicit Drug Use (2017-2019)
- Rhode Island: 10.8%
- Regional benchmark: 12.1%
- National benchmark: 8.2%
- RI elevated than national but reduced than regional
While Rhode Island youth drug use surpasses national benchmarks, it remains below regional benchmarks.
Young Adult Substance Use (Ages 18-25, 2017-2019)
Past-Year Marijuana Use
- Rhode Island: 45.8%
- Regional benchmark: 46.4%
- National benchmark: 35.0%
- No substantial alteration from 2002-2004 levels
Past-Year Marijuana Use Disorder
- Rhode Island: 7.0% (9,000 persons)
- Regional benchmark: 6.7%
- National benchmark: 5.6%
- Reduced from 2002-2004 levels
Past-Year Opioid Use Disorder
- Rhode Island: 0.9% (1,000 persons)
- Regional benchmark: 1.2%
- National benchmark: 1.0%
- No substantial alteration from 2015-2017
Past-Year Illicit Drug Use Disorder
- Rhode Island: 9.3% (12,000 persons)
- Regional benchmark: 9.1%
- National benchmark: 7.5%
- No substantial alteration from 2015-2017
One in five young adults in Rhode Island possesses a substance use disorder, considerably elevated than the national rate.
Adult Substance Use Patterns
Non-Medical Drug Use (Past Year)
- Rhode Island Value: 11.7% of adults reported using prescription substances non-medically in the previous 12 months
- National Position: 7th uppermost in the country
Rhode Island’s position as 7th uppermost for non-medical drug consumption signifies that prescription substance misuse and illicit drug consumption (beyond marijuana) continue to be considerable problems compared to alternative states.
Polysubstance Use Among Adults
Prevalence (2021 Behavioral Risk Factor Monitoring System)
- 5,639 persons completed BRFSS
- Representing 889,340 adults (weighted population)
Overall Multiple-Substance Consumption: 13.7% of adults
Number of Substances Used
- None: 66.8%
- One substance: 19.5%
- Two substances: 10.4%
- Three substances: 2.8%
- All four evaluated: 0.5%
Almost half of polysubstance users mix marijuana with excessive alcohol, producing compounded health and impairment hazards.
Demographic Variations in Substance Use (2021)
By Sex
| Classification | Males | Females |
| No substance consumption | 61.7% | 71.5% |
| One substance | 21.4% | 17.8% |
| Multiple-substance consumption | 16.9% | 10.8% |
By Age Category
| Age | No Substance | One Substance | Polysubstance |
| 18-24 | 56.9% | 17.1% | 26.0% |
| 25-34 | 56.8% | 23.4% | 19.6% |
| 35-44 | 68.1% | 22.4% | 9.6% |
| 45-64 | 82.1% | 14.4% | 3.6% |
| 65+ | 82.1% | 14.4% | 3.6% |
By Race/Ethnicity
| Race/Ethnicity | No Substance | One Substance | Polysubstance |
| White, Non-Hispanic | 64.5% | 21.2% | 14.3% |
| Black, Non-Hispanic | 74.2% | 15.8% | 10.0% |
| Other, Non-Hispanic | 74.1% | 13.1% | 12.8% |
| Hispanic | 71.2% | 16.3% | 12.4% |
Substance consumption patterns expose stark demographic disparities, with males and young adults aged 18-24 displaying the uppermost rates.
Substance Use Disorders
Overall Population (Ages 12+, 2022-2023)
| Disorder Category | Count | Proportion |
| Substance Use Disorder | 207,000 | 21.78% |
| Drug Use Disorder | 111,000 | 11.69% |
| Pain Reliever Use Disorder | 20,000 | 2.08% |
| Opioid Use Disorder | 22,000 | 2.28% |
By Age Category
| Age | Substance Use Disorder | Drug Use Disorder |
| 12-17 | 9.30% | 7.49% |
| 18-25 | 34.95% | 22.71% |
| 26+ | 20.85% | 10.32% |
| 18+ | 22.81% | 12.04% |
Over one in five Rhode Island residents aged 12+ has a substance use disorder.
Risk Perceptions (2022-2023)
Marijuana (Smoking Once a Month)
| Age Category | Count | Proportion |
| 12+ | 154,000 | 16.26% |
| 12-17 | 12,000 | 17.09% |
| 18-25 | 10,000 | 7.87% |
| 26+ | 132,000 | 17.55% |
| 18+ | 142,000 | 16.19% |
Cocaine (Using Once a Month)
| Age Category | Count | Proportion |
| 12+ | 579,000 | 61.09% |
| 12-17 | 32,000 | 43.72% |
| 18-25 | 67,000 | 54.40% |
| 26+ | 481,000 | 63.82% |
| 18+ | 548,000 | 62.51% |
Heroin (Trying Once or Twice)
| Age Category | Count | Proportion |
| 12+ | 768,000 | 81.01% |
| 12-17 | 38,000 | 52.91% |
| 18-25 | 92,000 | 75.38% |
| 26+ | 637,000 | 84.55% |
| 18+ | 729,000 | 83.27% |
Risk perceptions are minimal among young adults (18-25) across all substances, which corresponds with their elevated consumption rates.
Treatment Availability and Utilization
Treatment Gap (2022-2023)
| Age Category | Received Treatment | Classified as Needing | Not Receiving Among Those Needing |
| 12+ | 49,000 (5.17%) | 231,000 (24.29%) | 183,000 (78.70%) |
| 12-17 | 4,000 (5.33%) | 8,000 (11.26%) | 5,000 (57.91%) |
| 18-25 | 6,000 (4.57%) | 44,000 (36.31%) | 38,000 (86.47%) |
| 26+ | 40,000 (5.26%) | 178,000 (23.60%) | 140,000 (77.85%) |
| 18+ | 45,000 (5.16%) | 222,000 (25.37%) | 177,000 (79.55%) |
The treatment gapl represents a critical deficiency in Rhode Island’s substance misuse response infrastructure.
Substance Abuse Treatment Facilities and Capacity
Current Infrastructure
- 61 active substance misuse clinics in Rhode Island
- 8,609 patients serviced yearly for drug rehabilitation
- No facilities provide free drug rehabilitation intervention for all patients
Treatment Modality Breakdown (Annual)
- Outpatient services: 8,286 patients
- Residential (non-hospital) services: 265 patients
- Hospital-based drug rehabilitation: 58 patients
The overwhelming majority (96.2%) of intervention transpires in outpatient locations, with very restricted residential and hospital-based capacity.
Treatment Enrollment Patterns
Single-Day Count Contrast
- 2015: 14,269 individuals enrolled in substance consumption intervention
- 2019: 8,609 individuals enrolled
- Alteration: 40% reduction in enrollment
Treatment Focus (March 2019 single-day count)
- Drug problem exclusively: 65.7%
- Alcohol problem exclusively: 11.0%
- Both drug and alcohol problems: 23.3%
The dramatic 40% reduction in treatment enrollment from 2015 to 2019 is troubling, particularly given persistently elevated overdose rates.
Medication-Assisted Treatment (MAT)
Methadone Treatment (Single-Day Counts)
- 2015: 6,213 individuals receiving methadone in opioid intervention programs
- 2019: 4,222 individuals
- Alteration: 32% reduction
Buprenorphine Treatment (Single-Day Counts)
- 2015: 1,078 individuals receiving buprenorphine
- 2019: 814 individuals
- Alteration: 24% reduction
The considerable reductions in both methadone and buprenorphine treatment are troubling given the continuing opioid emergency.
Treatment Costs
Average Individual Treatment Costs
| Intervention Category | Rhode Island Expense |
| Residential Intervention | $58,755 |
| Outpatient Intervention | $1,673 |
National Cost Rankings
- Residential intervention: Rhode Island positions 39th (cheapest to most expensive)
- Outpatient intervention: Rhode Island is among the upper 10 most expensive states
Public Spending on Treatment
Outpatient Services
- Rhode Island expenditure: $13.86 million
- Share of U.S. total: 0.6%
Residential Treatment
- Rhode Island expenditure: $15.57 million
- Share of U.S. total: 0.3%
While residential treatment costs are moderate nationally, Rhode Island’s outpatient treatment is among the most expensive in the country.
Health Outcomes Associated with Substance Use
Adjusted Odds Ratios for Health Outcomes (2021)
| Health Indicator | One-Substance Consumption (AOR) | 95% CI | 95% CI |
| Fair/Poor Overall Health | 1.20 | 0.89-1.62 | 1.26-2.76 |
| Frequent Mental Distress | 1.67 | 1.25-2.23 | 1.88-3.87 |
| Diagnosed with Depression | 1.47 | 1.17-1.84 | 1.42-2.59 |
| Chronic Disease | 1.19 | 0.96-1.48 | 1.05-2.00 |
| Obesity | 1.03 | 0.83-1.29 | 0.58-1.11 |
- Polysubstance consumers are 1.86 times more prone to report fair/poor overall health
- Polysubstance consumers are 2.69 times more prone to experience frequent mental distress
- Polysubstance consumers are 1.92 times more prone to be diagnosed with depression
- Polysubstance consumers are 1.45 times more prone to have chronic disease
Poysubstance consumption is strongly connected with worse health outcomes, especially mental health.
Hepatitis C and HIV/AIDS Related to Drug Use
Hepatitis C (2022)
Estimated 7.3 new incidents per 100,000 residents linked to intravenous drug use
HIV/AIDS (2023)
Approximately 4.1 new diagnoses per 100,000 residents connected to intravenous drug use
While these rates may appear modest, they represent continuing public health challenges connected with injection drug use.
Federal Drug Crime Statistics
2023 Federal Prosecutions in Rhode Island
- Total federal criminal incidents: 106
- Drug-involved offenses: 33% of all federal prosecutions
Drug Categories Found in Federal Drug Incidents
| Drug Category | Proportion |
| Powder cocaine | 26.5% |
| Crack cocaine | 26.5% |
| Methamphetamines | 23.5% |
| Fentanyl | 14.7% |
| Marijuana | 5.9% |
| Heroin | 2.9% |
Cocaine (both powder and crack combined) represents more than half of federal drug prosecutions in Rhode Island.
Marijuana-Related Arrests
- 2012: 2,092 arrests
- 2023: 92 arrests
- Alteration: Over 95% reduction
State law amendments, including decriminalization and legalization measures, have dramatically reduced marijuana-involved arrests.
Final Words
Rhode Island is accomplishing considerable advancement in reducing overdose fatalities, yet the state still confronts overdose rates 16-34% elevated than national benchmarks and a critical intervention gap. Young adults (18-25) are disproportionately impacted, with over one-third possessing substance use disorders but the poorest treatment access. The recent transformation from fentanyl to cocaine as the primary overdose substance, combined with elevated rates of polysubstance consumption, shows that Rhode Island’s substance misuse emergency continues to be complex and necessitates continued expansion of intervention capacity, harm reduction initiatives, and focused interventions for high-risk populations.
Statistical Data on Alcohol in Rhode Island
Rhode Island confronts considerable alcohol-involved public health concerns. The state shows troubling patterns in young adult binge alcohol use, considerable disparities across demographic categories, and a critical shortage in substance misuse treatment availability. The information reveals both declining patterns in youth alcohol consumption and alarming escalations in alcohol-attributable mortality, especially among women and veterans. This thorough analysis examines drinking behaviors, mortality patterns, treatment requirements, demographic disparities, and risk perceptions across Rhode Island’s population from 2002 to 2023.
Overall Alcohol-Involved Fatalities
- Total yearly fatalities attributable to excessive alcohol use: 493
- Fatalities under age 21: 1.4% (approximately 7 fatalities)
- 5-year benchmark yearly rate escalation (2015-2019): 39.2%
- Fatality rate: 5.57 fatalities per 10,000 adults (1 fatality per 2,226 individuals aged 18+)
- Male fatalities: 67.5%
- Fatalities from chronic causes (e.g., Alcohol Consumption Disorder): 59.8%
- Fatalities among adults 35+ years: 87.4%
- Fatalities under age 21: 1.42%
- Years of potential life lost yearly: 12,094
- Economic expense (2010, adjusted to 2022 dollars): $1.197 billion ($2.46 per beverage)
Rhode Island experiences a considerable burden from excessive alcohol use, with approximately 500 fatalities yearly.
Fully Alcohol-Attributable Chronic Condition Deaths (2018-2022)
Annual Death Statistics
| Year | Total Fatalities (All Causes) | Alcohol-Attributable Fatalities | Proportion |
| 2018 | 9,703 | 354 | 3.6% |
| 2019 | 9,806 | 361 | 3.7% |
| 2020 | 11,328 | 434 | 3.8% |
| 2021 | 10,875 | 357 | 3.3% |
| 2022 | 10,518 | 328 | 3.1% |
| 5-Year Benchmark | 10,446 | 367 | 3.5% |
Causes of Fatality
- Alcoholic liver disease: 63.2%
- Alcohol dependence syndrome: 22.2%
- Alcohol abuse: 8.3%
- Age-adjusted fatality rate: 28.8 fatalities per 100,000 individuals
- No considerable monthly or seasonal alterations observed
Fatalities from fully alcohol-attributable chronic conditions represent a considerable portion of all mortality in Rhode Island, averaging 367 fatalities yearly (3.5% of all fatalities).
Gender Distribution
| Year | Male Fatalities | Female Fatalities | Male:Female Ratio |
| 2018 | 278 (78.5%) | 76 (21.5%) | 3.7:1 |
| 2019 | 273 (75.6%) | 88 (24.4%) | 3.1:1 |
| 2020 | 347 (80.0%) | 87 (20.0%) | 4.0:1 |
| 2021 | 269 (75.4%) | 88 (24.6%) | 3.1:1 |
| 2022 | 226 (68.9%) | 102 (31.1%) | 2.2:1 |
| 5-Year Benchmark | 279 (76.0%) | 88 (24.0%) | 3.2:1 |
- Escalation in female fatalities (2018-2022): 34.2%
- Overall ratio: 3.2 male fatalities for every 1 female fatality
Male fatalities outnumber female fatalities by more than 3:1 overall, though this disparity has narrowed considerably over the five-year timeframe.
Age Distribution (5-Year Benchmark)
| Age Category | Benchmark Fatalities | Proportion |
| 0-24 | 5 | 1.3% |
| 25-34 | 23 | 6.2% |
| 35-44 | 47 | 12.8% |
| 45-54 | 69 | 18.7% |
| 55-64 | 121 | 33.1% |
| 65+ | 103 | 28.0% |
- Ages 55+: 60% of fatalities
- Ages 65+ in 2018: 21.5%
- Ages 65+ in 2022: 33.2%
Most fatalities occur among middle-aged and older adults, with over 60% of decedents aged 55 or older.
Race/Ethnicity Distribution (5-Year Benchmark)
| Race/Ethnicity | Benchmark Fatalities | Proportion |
| White, Non-Hispanic | 297 | 80.9% |
| Black, Non-Hispanic | 17 | 4.5% |
| Hispanic | 30 | 8.2% |
| Other, Non-Hispanic | 24 | 6.4% |
The overwhelming majority of fatalities occur among non-Hispanic white persons, followed by Hispanic persons.
Veteran Status
- Veteran fatalities (5-year benchmark): 46 (12.8%)
- Non-veteran fatalities (5-year benchmark): 313 (87.2%)
- Veteran population in Rhode Island: 6%
- Disproportionate impact: Veterans represent 12.8% of fatalities but only 6% of population
- Veterans reporting past-month alcohol use: 67%
- Veterans reporting past-month binge drinking: 19%
Veterans are disproportionately impacted by alcohol-attributable chronic conditions.
Age-Specific Alcohol Use Patterns
Youth (Ages 12-17)
- Past-month alcohol use: 8.36% (6,000 youth)
- Past-month binge drinking: 3.79% (3,000 youth)
- Alcohol use disorder: 3.19% (2,000 youth)
- Past-month alcohol use (2017-2019 benchmark): 10.1% (7,000 youth) – reduced from 2002-2004
- Contrast: Comparable to regional benchmark (12.6%) and national benchmark (9.4%)
Youth alcohol use in Rhode Island has displayed positive patterns, with considerable reductions in past-month alcohol use between 2002-2004 and 2017-2019.
Ages 12-20
- Past-month alcohol use: 20.10% (23,000 individuals)
- Past-month binge drinking: 11.20% (13,000 individuals)
- Alcohol use disorder: 7.07% (8,000 individuals)
- Perception of great risk from binge drinking: 41.83% (49,000 individuals)
This age category, which spans both adolescence and early young adulthood, displays troubling patterns of alcohol use despite being below the legal drinking age.
Young Adults (Ages 18-25)
- Past-month alcohol use: 58.02% (71,000 young adults)
- Past-month binge drinking: 37.28% (46,000 young adults)
- Past-month binge drinking (2017-2019 benchmark): 46.7% (58,000 young adults) – no considerable alteration from 2015-2017
- Contrast: Comparable to regional benchmark (46.6%) but elevated than national benchmark (35.4%)
- Alcohol use disorder: 19.17% (23,000 young adults)
- Alcohol use disorder (2017-2019 benchmark): 14.4% (18,000 young adults) – reduced from 2002-2004
- Contrast: Comparable to regional benchmark (13.7%) but elevated than national benchmark (9.8%)
- Perception of great risk from binge drinking: 40.45% (50,000 young adults)
- Binge alcohol use most prevalent in ages 18-34: approximately 30%
Young adults in Rhode Island display especially elevated rates of problematic alcohol use compared to national benchmarks.
Adults (Ages 26+)
- Past-month alcohol use: 58.89% (444,000 adults)
- Past-month binge drinking: 25.88% (195,000 adults)
- Alcohol use disorder: 12.43% (94,000 adults)
- Perception of great risk from binge drinking: 47.45% (358,000 adults)
Alcohol use continues to be widespread among older adults, with approximately 60% reporting past-monthuse.
Demographic Disparities in Alcohol Use
Gender Differences
- Males – past-month alcohol use: 66.2%
- Females – past-month alcohol use: 56.9%
- Males – past-month binge drinking: 17.5%
- Females – past-month binge drinking: 9.4%
- Male binge drinking rate is approximately 2x female rate
Considerable gender disparities exist in Rhode Island’s drinking patterns. Men report both elevated rates of any alcohol use and approximately double the rate of binge drinking compared to women.
Race and Ethnicity
- Non-Hispanic White – past-month alcohol use: 63.7%
- Non-Hispanic Black, Hispanic/Latinx, Non-Hispanic other/multiple races – past-month alcohol use: approximately 50%
- Non-Hispanic Black – past-month binge drinking: 13.7%
- Non-Hispanic other/multiple races – past-month binge drinking: 13.8%
- Hispanic/Latinx – past-month binge drinking: 14.3%
Drinking patterns display notable variation across racial and ethnic categories.
Risk Perception (5+ beverages once or twice per week)
| Age Category | Count | Proportion |
| 12+ | 437,000 | 46.11% |
| 12-17 | 30,000 | 41.68% |
| 18-25 | 50,000 | 40.45% |
| 26+ | 358,000 | 47.45% |
| 18+ | 407,000 | 46.47% |
| 12-20 | 49,000 | 41.83% |
Perceptions of risk from heavy drinking vary by age, with older adults and youth more prone to perceive binge drinkin as risky compared to young adults.
Alcohol Use Disorder
Prevalence (2022-2023)
| Age Category | Count with AUD | Proportion with AUD |
| 12+ | 119,000 | 12.59% |
| 12-17 | 2,000 | 3.19% |
| 18-25 | 23,000 | 19.17% |
| 26+ | 94,000 | 12.43% |
| 18+ | 117,000 | 13.37% |
| 12-20 | 8,000 | 7.07% |
Overall Population (Ages 12+) – 2017-2019
- Alcohol use disorder: 6.5% (59,000 individuals) – reduced from 2002-2004
- Contrast: Comparable to regional benchmark (6.4%) and national benchmark (5.3%)
Treatment Needs and Trends
Treatment Access and Gaps
- Received substance use treatment: 5.17% (49,000 individuals aged 12+)
- Classified as needing treatment: 24.29% (231,000 individuals aged 12+)
- Not receiving treatment among those needing it: 78.70% (183,000 individuals aged 12+)
- Youth (12-17)not receiving needed treatment: 57.91% (5,000 youth)
- Young adults (18-25) not receiving needed treatment: 86.47% (38,000 young adults)
- Adults (26+) not receiving needed treatment: 77.85% (140,000 adults)
- Number of alcohol and drug rehabs in Rhode Island: 60
- National ranking: Among top 10 highest for unmet treatment needs, especially for 18-25 age group
Rhode Island confronts a considerable treatment gap, with approximately 80% of those classified as requiring substance use treatment not receiving it.
Treatment Admission
- Alcohol abuse treatment admissions (1992): 53%
- Alcohol abuse treatment admissions (2006): 29%
- Drug-only treatment admissions (1992): 21%
- Drug-only treatment admissions (2006): 46%
- Gender composition: Men comprise the majority of alcohol abuse treatment admissions (primary or secondary substance)
Rhode Island has experienced a dramatic transformation in the composition of substance abuse treatment admissions since 1992. Alcohol-only treatment admissions have declined considerably, while drug-only admissions have doubled during the identical timeframe.
Final Words
Rhode Island confronts considerable alcohol-involved public health challenges, with intake rates persistently exceeding national benchmarks and an alarming treatment gap impacting approximately 80% of those who require assistance. Young adults aged 18-25 are especially at risk, displaying binge drinking rates approximately 50% and alcohol use disorder rates of 19% that far exceed national standards. While some positive patterns exist, such as declining youth alcohol use and a recent reduction in excessive drinking rates, the 39% escalation in alcohol-attributable fatalities from 2015-2019 and the disproportionate impact on vulnerable populations show an urgent requirement for expanded prevention, intervention, and focused treatment programs across the state.
Conclusion
In general, Rhode Island confronts a multifaceted substance misuse emergency characterized by overdose rates 16-34% elevated than national benchmarks, though the state has achieved encouraging advancement with a 25% reduction in overdose fatalities from 2022 to 2024. Despite this progress, critical challenges persist: approximately 80% of those requiring substance use treatment are not receiving it, young adults aged 18-25 confront extraordinarily elevated rates of both alcohol use disorder (19%) and substance use disorder (35%), and vulnerable populations display disproportionately elevated rates of problematic use and mortality. The dramatic transformation from opioid-dominant to cocaine-involved overdoses, combined with widespread polysubstance use (especially marijuana and alcohol mixtures), underscores the evolving complexity of the emergency and the urgent requirement for expanded treatment capacity, harm reduction approaches, and focused interventions addressing the particular requirements of high-risk demographic categories across all age ranges.
Sources:
- Drug Abuse Statistics
- Rhode Island Drug Crime Statistics – Updated 2026
- RHODE ISLAND – National Survey on Drug Use and Health
- Youth and Substance Abuse: Addressing the Growing Concern in Rhode Island
- R.I. overdose deaths decline for second year in a row
- Rhode Island Drug Abuse Statistics | Recovery Connection
- Non-Medical Drug Use – Past Year in Rhode Island
- Behavioral Health Barometer: Rhode Island, Volume 6
- Polysubstance Use Among Rhode Island Adults
- Alcohol Use Among Adults in Rhode Island, 2016-2020
- Deaths Involving Fully Alcohol-Attributable Chronic Conditions in Rhode Island: 2018-2022